Altria (MO) investors got smoke in their eyes on Wednesday, seeing the shares shed 9% in the session. The decline came on account of a report stating the FDA is readying to order Juul to pull its vapor products off the market. The tobacco giant best known as the seller of Marlboro cigarettes, acquired a 35% in Juul in 2018, which represents an important part of Altria’s reduced-risk product portfolio. According to the reports, JUUL can appeal the decision, but in any case, the products will be taken off the shelves immediately. The company claims almost 26% of vapor market share and is second only to BAT’s Vuse products.
https://www.tipranks.com/news/article/is-altria-stock-a-buy-despite-fda-plans-to-take-juul-products-off-the-market-analyst-weighs-in?utm_source=advfn.com&utm_medium=referral
Altria (NYSE:MO)
Graphique Historique de l'Action
De Juil 2022 à Août 2022 Plus de graphiques de la Bourse Altria
Altria (NYSE:MO)
Graphique Historique de l'Action
De Août 2021 à Août 2022 Plus de graphiques de la Bourse Altria